This clinical overview details the latest evidence-based strategies for diagnosing and treating symptoms of benign prostatic hyperplasia in men.

The FDA has approved tadalafil (Cialis) for the once daily use as a treatment for benign prostatic hyperplasia (BPH). The agency also approved the medication for once daily use as a treatment for men ...

Treatment with vibegron reduced the average number of micturition episodes per day and the average number of daily urgency episodes compared with placebo. The Food and Drug Administration (FDA) has ...

Teleflex Incorporated announced the presentation of multiple clinical studies at the 2025 American Urological Association Annual Meeting in Las Vegas, highlighting advancements in treatments for ...

Benign prostatic hyperplasia (BPH) is one of the most common urologic conditions affecting men as they age, with nearly 50% of men over 50 experiencing symptoms. Despite its prevalence, treatment ...

BPH is a natural enlargement of the prostate. 50 percent of men in their 50′s will have this condition, along with 80 percent of men in their 80′s. Frequent need to use the bathroom is a common side ...

These new findings are important as α-blockers (ABs) are the most prescribed class of medications for patients with benign prostatic hyperplasia (BPH), but the cardiovascular safety profile of this ...

Our extensive research on the Benign Prostatic Hyperplasia Treatment (2024-2032) offers valuable insights for businesses. This comprehensive report delves into emerging trends, in ...

Add Yahoo as a preferred source to see more of our stories on Google. Men aged 50 and above are most commonly affected. (Getty Images) (Rafael Ben-Ari via Getty Images) This common condition affects ...

CHICAGO, Ill. (IVANHOE NEWSWIRE)- Benign prostatic hyperplasia, or BPH, is a natural enlargement of the prostate. 50 percent of men in their 50′s will have this condition, along with 80 percent of men ...